These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29661523)

  • 1. A positive-psychological intervention reduces acute psychosis-proneness.
    Grant P; Munk AJL; Hennig J
    Schizophr Res; 2018 Sep; 199():414-419. PubMed ID: 29661523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizotypy, social stress and the emergence of psychotic-like states - A case for benign schizotypy?
    Grant P; Hennig J
    Schizophr Res; 2020 Feb; 216():435-442. PubMed ID: 31796309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample.
    Flückiger R; Ruhrmann S; Debbané M; Michel C; Hubl D; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    J Abnorm Psychol; 2016 Oct; 125(7):923-932. PubMed ID: 27583768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.
    Cicero DC; Jonas KG; Li K; Perlman G; Kotov R
    Schizophr Bull; 2019 Oct; 45(6):1336-1348. PubMed ID: 30753725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
    Brosey E; Woodward ND
    Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of Schizotypal Features in Unaffected First-Degree Relatives of Schizophrenia Patients.
    Lui SSY; Hung KSY; Wang Y; Ho KKY; Yeung HKH; Wang Y; Huang J; Gooding DC; Cheung EFC; Chan RCK
    Schizophr Bull; 2018 Oct; 44(suppl_2):S536-S546. PubMed ID: 29618094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing psychosis and its risk states through the lens of schizotypy.
    Debbané M; Eliez S; Badoud D; Conus P; Flückiger R; Schultze-Lutter F
    Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S396-407. PubMed ID: 25548386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders.
    Barrantes-Vidal N; Grant P; Kwapil TR
    Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S408-16. PubMed ID: 25810055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of prodromal symptoms and schizophrenia-spectrum personality disorder traits by positive and negative schizotypy: A 3-year prospective study.
    Racioppi A; Sheinbaum T; Gross GM; Ballespí S; Kwapil TR; Barrantes-Vidal N
    PLoS One; 2018; 13(11):e0207150. PubMed ID: 30408119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk for schizophrenia as a moderator of associations between childhood trauma and schizotypy.
    Tonini E; Watkeys O; Quidé Y; Whitford TJ; Cairns MJ; Green MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110612. PubMed ID: 35961623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subnormal sensory attenuation to self-generated speech in schizotypy: Electrophysiological evidence for a 'continuum of psychosis'.
    Oestreich LK; Mifsud NG; Ford JM; Roach BJ; Mathalon DH; Whitford TJ
    Int J Psychophysiol; 2015 Aug; 97(2):131-8. PubMed ID: 26027781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizotypy: phenotypic marker as risk factor.
    Catts SV; Fox AM; Ward PB; McConaghy N
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S101-7. PubMed ID: 11129293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms.
    Barrantes-Vidal N; Gross GM; Sheinbaum T; Mitjavila M; Ballespí S; Kwapil TR
    Schizophr Res; 2013 Apr; 145(1-3):50-5. PubMed ID: 23402694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional support for the cognitive model of schizophrenia: evidence of elevated defeatist beliefs in schizotypy.
    Luther L; Salyers MP; Firmin RL; Marggraf MP; Davis B; Minor KS
    Compr Psychiatry; 2016 Jul; 68():40-7. PubMed ID: 27234181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
    Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
    Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
    Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
    Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter.
    Flückiger R; Michel C; Grant P; Ruhrmann S; Vogeley K; Hubl D; Schimmelmann BG; Klosterkötter J; Schmidt SJ; Schultze-Lutter F
    Schizophr Res; 2019 Aug; 210():188-196. PubMed ID: 30683524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathology, social adjustment and personality correlates of schizotypy clusters in a large nonclinical sample.
    Barrantes-Vidal N; Lewandowski KE; Kwapil TR
    Schizophr Res; 2010 Sep; 122(1-3):219-25. PubMed ID: 20138738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental profiles of schizotypy in the general population: A record linkage study of Australian children aged 11-12 years.
    Green MJ; O'Hare K; Laurens KR; Tzoumakis S; Dean K; Badcock JC; Harris F; Linscott RJ; Carr VJ
    Br J Clin Psychol; 2022 Sep; 61(3):836-858. PubMed ID: 35229307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment.
    Nordentoft M; Thorup A; Petersen L; Ohlenschlaeger J; Melau M; Christensen TØ; Krarup G; Jørgensen P; Jeppesen P
    Schizophr Res; 2006 Mar; 83(1):29-40. PubMed ID: 16504481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.